{"id":46979,"date":"2022-08-05T13:02:28","date_gmt":"2022-08-05T11:02:28","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/click-therapeutics-to-present-at-the-canaccord-genuity-42nd-annual-growth-conference\/"},"modified":"2022-08-05T13:02:28","modified_gmt":"2022-08-05T11:02:28","slug":"click-therapeutics-to-present-at-the-canaccord-genuity-42nd-annual-growth-conference","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/click-therapeutics-to-present-at-the-canaccord-genuity-42nd-annual-growth-conference\/","title":{"rendered":"Click Therapeutics to Present at the Canaccord Genuity 42nd Annual Growth Conference"},"content":{"rendered":"
\n

NEW YORK–(BUSINESS WIRE)–Click Therapeutics, Inc.<\/a> (\u201cClick\u201d), a leader in Digital Therapeutics\u2122 as prescription medical treatments, today announced that Randall Stanicky, Chief Financial Officer, will present at the Canaccord Genuity 42nd Annual Growth Conference on Thursday, August 11, 2022 at 12:30 p.m. ET.\n<\/p>\n

<\/a><\/p>\n

\nCompany management will also participate in one-on-one meetings during the conference, which will be held August 8-11, 2022 in Boston, Massachusetts.\n<\/p>\n

\nAbout Click Therapeutics<\/b>\n<\/p>\n

\nClick Therapeutics, Inc. develops and commercializes software as prescription medical treatments for patients with unmet medical needs. Through cognitive and neurobehavioral mechanisms, Click\u2019s Digital Therapeutics\u2122 enable change within individuals, and are designed to be used independently or in conjunction with biomedical treatments. The Clickometrics\u00ae<\/sup> adaptive data science platform continuously personalizes user experience to optimize engagement and outcomes. Following a groundbreaking clinical trial, Click\u2019s industry-leading smoking cessation program is available nationwide through a wide variety of payers, providers, and employers. Click\u2019s lead prescription program has recently entered a pivotal, fully remote, randomized, controlled trial on the Verily platform for the treatment of Major Depressive Disorder (MDD) in up to 360 adults. Click is progressing a broad pipeline of Digital Therapeutics\u2122 across a variety of high-burden therapeutic areas, including MDD, Schizophrenia, Migraine, Chronic Pain, Atopic Dermatitis, Acute Coronary Syndrome (ACS), Obesity and more. For more information on Click, visit ClickTherapeutics.com.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nCompany<\/b>
Daniel Busby
\n
VP, Investor Relations & Strategic Finance
\n
dbusby@clicktherapeutics.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

NEW YORK–(BUSINESS WIRE)–Click Therapeutics, Inc. (\u201cClick\u201d), a leader in Digital Therapeutics\u2122 as prescription medical treatments, today announced that Randall Stanicky, Chief Financial Officer, will present at the Canaccord Genuity 42nd Annual Growth Conference on Thursday, August 11, 2022 at 12:30 p.m. ET. Company management will also participate in one-on-one meetings during the conference, which will … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-46979","6":"format-standard","7":"category-industry"},"yoast_head":"\nClick Therapeutics to Present at the Canaccord Genuity 42nd Annual Growth Conference - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/click-therapeutics-to-present-at-the-canaccord-genuity-42nd-annual-growth-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Click Therapeutics to Present at the Canaccord Genuity 42nd Annual Growth Conference - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"NEW YORK–(BUSINESS WIRE)–Click Therapeutics, Inc. (\u201cClick\u201d), a leader in Digital Therapeutics\u2122 as prescription medical treatments, today announced that Randall Stanicky, Chief Financial Officer, will present at the Canaccord Genuity 42nd Annual Growth Conference on Thursday, August 11, 2022 at 12:30 p.m. ET. Company management will also participate in one-on-one meetings during the conference, which will ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/click-therapeutics-to-present-at-the-canaccord-genuity-42nd-annual-growth-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-08-05T11:02:28+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220805005027\/en\/1473760\/21\/CT_Lock-up_CMYK_Black.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/click-therapeutics-to-present-at-the-canaccord-genuity-42nd-annual-growth-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/click-therapeutics-to-present-at-the-canaccord-genuity-42nd-annual-growth-conference\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Click Therapeutics to Present at the Canaccord Genuity 42nd Annual Growth Conference\",\"datePublished\":\"2022-08-05T11:02:28+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/click-therapeutics-to-present-at-the-canaccord-genuity-42nd-annual-growth-conference\\\/\"},\"wordCount\":241,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/click-therapeutics-to-present-at-the-canaccord-genuity-42nd-annual-growth-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220805005027\\\/en\\\/1473760\\\/21\\\/CT_Lock-up_CMYK_Black.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/click-therapeutics-to-present-at-the-canaccord-genuity-42nd-annual-growth-conference\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/click-therapeutics-to-present-at-the-canaccord-genuity-42nd-annual-growth-conference\\\/\",\"name\":\"Click Therapeutics to Present at the Canaccord Genuity 42nd Annual Growth Conference - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/click-therapeutics-to-present-at-the-canaccord-genuity-42nd-annual-growth-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/click-therapeutics-to-present-at-the-canaccord-genuity-42nd-annual-growth-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220805005027\\\/en\\\/1473760\\\/21\\\/CT_Lock-up_CMYK_Black.jpg\",\"datePublished\":\"2022-08-05T11:02:28+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/click-therapeutics-to-present-at-the-canaccord-genuity-42nd-annual-growth-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/click-therapeutics-to-present-at-the-canaccord-genuity-42nd-annual-growth-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/click-therapeutics-to-present-at-the-canaccord-genuity-42nd-annual-growth-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220805005027\\\/en\\\/1473760\\\/21\\\/CT_Lock-up_CMYK_Black.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220805005027\\\/en\\\/1473760\\\/21\\\/CT_Lock-up_CMYK_Black.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/click-therapeutics-to-present-at-the-canaccord-genuity-42nd-annual-growth-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Click Therapeutics to Present at the Canaccord Genuity 42nd Annual Growth Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Click Therapeutics to Present at the Canaccord Genuity 42nd Annual Growth Conference - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/click-therapeutics-to-present-at-the-canaccord-genuity-42nd-annual-growth-conference\/","og_locale":"en_US","og_type":"article","og_title":"Click Therapeutics to Present at the Canaccord Genuity 42nd Annual Growth Conference - Pharma Trend","og_description":"NEW YORK–(BUSINESS WIRE)–Click Therapeutics, Inc. (\u201cClick\u201d), a leader in Digital Therapeutics\u2122 as prescription medical treatments, today announced that Randall Stanicky, Chief Financial Officer, will present at the Canaccord Genuity 42nd Annual Growth Conference on Thursday, August 11, 2022 at 12:30 p.m. ET. Company management will also participate in one-on-one meetings during the conference, which will ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/click-therapeutics-to-present-at-the-canaccord-genuity-42nd-annual-growth-conference\/","og_site_name":"Pharma Trend","article_published_time":"2022-08-05T11:02:28+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220805005027\/en\/1473760\/21\/CT_Lock-up_CMYK_Black.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/click-therapeutics-to-present-at-the-canaccord-genuity-42nd-annual-growth-conference\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/click-therapeutics-to-present-at-the-canaccord-genuity-42nd-annual-growth-conference\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Click Therapeutics to Present at the Canaccord Genuity 42nd Annual Growth Conference","datePublished":"2022-08-05T11:02:28+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/click-therapeutics-to-present-at-the-canaccord-genuity-42nd-annual-growth-conference\/"},"wordCount":241,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/click-therapeutics-to-present-at-the-canaccord-genuity-42nd-annual-growth-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220805005027\/en\/1473760\/21\/CT_Lock-up_CMYK_Black.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/click-therapeutics-to-present-at-the-canaccord-genuity-42nd-annual-growth-conference\/","url":"https:\/\/pharma-trend.com\/en\/click-therapeutics-to-present-at-the-canaccord-genuity-42nd-annual-growth-conference\/","name":"Click Therapeutics to Present at the Canaccord Genuity 42nd Annual Growth Conference - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/click-therapeutics-to-present-at-the-canaccord-genuity-42nd-annual-growth-conference\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/click-therapeutics-to-present-at-the-canaccord-genuity-42nd-annual-growth-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220805005027\/en\/1473760\/21\/CT_Lock-up_CMYK_Black.jpg","datePublished":"2022-08-05T11:02:28+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/click-therapeutics-to-present-at-the-canaccord-genuity-42nd-annual-growth-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/click-therapeutics-to-present-at-the-canaccord-genuity-42nd-annual-growth-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/click-therapeutics-to-present-at-the-canaccord-genuity-42nd-annual-growth-conference\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220805005027\/en\/1473760\/21\/CT_Lock-up_CMYK_Black.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220805005027\/en\/1473760\/21\/CT_Lock-up_CMYK_Black.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/click-therapeutics-to-present-at-the-canaccord-genuity-42nd-annual-growth-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Click Therapeutics to Present at the Canaccord Genuity 42nd Annual Growth Conference"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/46979","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=46979"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/46979\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=46979"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=46979"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=46979"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}